Institutional investors purchased a net $764.9 thousand shares of RGEN during the quarter ended June 2015 and now own 94.16% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RS INVESTMENT MANAGEMENT CO. LLC Bought 1.4 Million shares of Repligen Corp
FIDELITY MANAGEMENT & RESEARCH C... Bought 949.9 Thousand shares of Repligen Corp
OPPENHEIMERFUNDS, INC. Bought 488.8 Thousand shares of Repligen Corp